Jan 20, 2012 | Laboratory Instruments & Laboratory Equipment, Laboratory News, Laboratory Pathology
Researchers believe that clinical laboratory assays that use aptamers would have multiple advantages when compared to diagnostic tests utilizing anti-bodies
New diagnostic technology has been developed that has the potential to accurately detect such diseases as cancer and diabetes, even when the patient is pre-symptomatic. Not only would medical laboratory tests using this technology be low cost and portable, but some experts think that diagnostic assays using this technology could make it through the regulatory process and be cleared for clinical use in just five years or less.
This highly-sensitive diagnostic technology is able to detect specific proteins in human blood. It was developed by a research team at the University of Toledo in Ohio. Last fall, they published their findings in the Optical Society’s (OSA) open-access journal, Biomedical Optics Express.
(more…)
Dec 9, 2009 | Laboratory News, Laboratory Pathology
There’s a green bonus: GenVault’s new storage systems can reduce a clinical laboratory’s carbon footprint
Innovative laboratory technologies continue to disrupt the status quo as new products and services enter the marketplace. Among them is new dry-storage technology from Carlsbad, California-based GenVault Corp. that allows biological specimens to be stored at room temperature. It is a technology that has applications for medical laboratories and pathology groups.
(more…)
Oct 5, 2009 | Laboratory News, Laboratory Pathology
Up to 400 times more sensitive than existing ELISA-based methods
Detecting any of seven cancers in their earliest stages may be feasible through the use of a new biomarker chip that was recently unveiled by scientists from Stanford University’s Center for Magnetic Nanotechnology. To give their biomarker chip increased sensitivity over fluorescent detection methods, the scientists use magnetic technologies to accomplish detection.
Reporting in Proceedings of the National Academy of Sciences (PNAS), lead scientist Shan X. Wang, Ph.D., director of the center and professor of materials science and electrical engineering, says the chip is able to detect very low levels of seven cancers. The biodetection chip is to be marketed by Silicon Valley startup MagArray Inc., of Sunnyvale, California. It detects multiple proteins in blood or DNA strands using magnetic technology similar to how a computer reads a hard drive. Developers say this chip could also be used to diagnose cardiovascular disease and monitor cancer therapy.
(more…)
